abstract |
The invention discloses a salt form, a crystal form of a 1,2,4-triazine-3,5-dione (formula I) compound and a preparation method thereof, and its use in treatment and/or pharmaceutical preparation. The use described is in the treatment of diseases associated with thyroid hormone receptors. |